These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 8557170

  • 1. Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides.
    Behan DP, De Souza EB, Lowry PJ, Potter E, Sawchenko P, Vale WW.
    Front Neuroendocrinol; 1995 Oct; 16(4):362-82. PubMed ID: 8557170
    [Abstract] [Full Text] [Related]

  • 2. Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins.
    Potter E, Behan DP, Fischer WH, Linton EA, Lowry PJ, Vale WW.
    Nature; 1991 Jan 31; 349(6308):423-6. PubMed ID: 1846945
    [Abstract] [Full Text] [Related]

  • 3. Monkey corticotropin-releasing factor1 receptor: Complementary DNA cloning and pharmacological characterization.
    Oshida Y, Ikeda Y, Chaki S, Okuyama S.
    Life Sci; 2004 Feb 27; 74(15):1911-24. PubMed ID: 14761672
    [Abstract] [Full Text] [Related]

  • 4. Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists.
    Hoare SR, Sullivan SK, Schwarz DA, Ling N, Vale WW, Crowe PD, Grigoriadis DE.
    Biochemistry; 2004 Apr 06; 43(13):3996-4011. PubMed ID: 15049707
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor.
    Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C.
    Nature; 1995 Nov 16; 378(6554):287-92. PubMed ID: 7477349
    [Abstract] [Full Text] [Related]

  • 8. Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein: implications for the treatment of CNS disorders.
    Behan DP, Grigoriadis DE, Lovenberg T, Chalmers D, Heinrichs S, Liaw C, De Souza EB.
    Mol Psychiatry; 1996 Sep 16; 1(4):265-77. PubMed ID: 9118350
    [Abstract] [Full Text] [Related]

  • 9. Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism.
    Dautzenberg FM, Wille S.
    Regul Pept; 2004 May 15; 118(3):165-73. PubMed ID: 15003833
    [Abstract] [Full Text] [Related]

  • 10. Corticotropin-releasing factor binding protein enters the regulated secretory pathway in neuroendocrine cells and cortical neurons.
    Blanco EH, Zúñiga JP, Andrés ME, Alvarez AR, Gysling K.
    Neuropeptides; 2011 Aug 15; 45(4):273-9. PubMed ID: 21624661
    [Abstract] [Full Text] [Related]

  • 11. Corticotropin-releasing factor and its binding protein in human plasma.
    Lowry PJ.
    Ciba Found Symp; 1993 Aug 15; 172():108-15; discussion 115-28. PubMed ID: 8387905
    [Abstract] [Full Text] [Related]

  • 12. Impact of N-terminal domains for corticotropin-releasing factor (CRF) receptor-ligand interactions.
    Klose J, Fechner K, Beyermann M, Krause E, Wendt N, Bienert M, Rudolph R, Rothemund S.
    Biochemistry; 2005 Feb 08; 44(5):1614-23. PubMed ID: 15683245
    [Abstract] [Full Text] [Related]

  • 13. Differential expression of corticotropin-releasing factor (CRF) and urotensin I precursor genes, and evidence of CRF gene expression regulated by cortisol in goldfish brain.
    Bernier NJ, Lin X, Peter RE.
    Gen Comp Endocrinol; 1999 Dec 08; 116(3):461-77. PubMed ID: 10603283
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cloning and characterization of a short variant of the corticotropin-releasing factor receptor subtype from rat amygdala.
    Miyata I, Shiota C, Ikeda Y, Oshida Y, Chaki S, Okuyama S, Inagami T.
    Biochem Biophys Res Commun; 1999 Mar 24; 256(3):692-6. PubMed ID: 10080961
    [Abstract] [Full Text] [Related]

  • 17. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
    Grigoriadis DE, Liu XJ, Vaughn J, Palmer SF, True CD, Vale WW, Ling N, De Souza EB.
    Mol Pharmacol; 1996 Sep 24; 50(3):679-86. PubMed ID: 8794910
    [Abstract] [Full Text] [Related]

  • 18. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity.
    Hoare SR, Sullivan SK, Fan J, Khongsaly K, Grigoriadis DE.
    Peptides; 2005 Mar 24; 26(3):457-70. PubMed ID: 15652653
    [Abstract] [Full Text] [Related]

  • 19. Distribution of corticotropin-releasing factor binding protein-immunoreactivity in the rat hypothalamus: association with corticotropin-releasing factor-, urocortin 1- and vimentin-immunoreactive fibres.
    Henry BA, Lightman SL, Lowry CA.
    J Neuroendocrinol; 2005 Mar 24; 17(3):135-44. PubMed ID: 15796765
    [Abstract] [Full Text] [Related]

  • 20. A variant of the human corticotropin-releasing factor (CRF) receptor: cloning, expression and pharmacology.
    Ross PC, Kostas CM, Ramabhadran TV.
    Biochem Biophys Res Commun; 1994 Dec 30; 205(3):1836-42. PubMed ID: 7811272
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.